Shingles Vaccine Market Share, Size, Regional Outlook, Industry Analysis, Growth, Segmentation and Forecast To 2028

Report Summary

Eternity Insights has published a new study on Global Shingles Vaccine Market focusing on key segments as by Type (Zostavax,Shingrix, Other), by Application (Under 50 Years Old,50-60 Years Old,60-70 Years Old,Above 70 Years Old), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Shingles Vaccine Market.

The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.

Shingles Vaccine Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Global Shingles Vaccine Market Size, 2018-2028 (USD Million)

Global Shingles Vaccine Market Segmentation:

Shingles Vaccine Market, By Type

• Zostavax
• Shingrix
• Other

Shingles Vaccine Market, By Application

• Under 50 Years Old
• 50-60 Years Old
• 60-70 Years Old
• Above 70 Years Old

Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Shingles Vaccine market in terms of demand generation. The Shingles Vaccine market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Shingles Vaccine market for below listed coun-tries across each region.

North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).

Global Shingles Vaccine Market Taxonomy:

Global Shingles Vaccine Market Competitive Landscape

The global Shingles Vaccine market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details

• Company Overview
• Financial Analysis
• Product Portfolio Analysis
• Strategic Overview
• SWOT Analysis

List of Companies Profiled in the report:

• GlaxoSmithKline plc.
• SK chemicals
• Green Cross Corp
• CanSinoBIO
• Geneone Life Science
• Vaccitech
• Other Players of Specific Interest can be added based on requirement

Market Segmentation

Key Benefits to the stake holders

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come

Table Of Contents

Table of Contents

1 Shingles Vaccine Market Overview
1.1 Shingles Vaccine Product Overview
1.2 Shingles Vaccine Market Segment by Type
1.2.1 Zostavax
1.2.2 Shingrix
1.3 Global Shingles Vaccine Market Size by Type
1.3.1 Global Shingles Vaccine Sales and Growth by Type
1.3.2 Global Shingles Vaccine Sales and Market Share by Type (2017-2020)
1.3.3 Global Shingles Vaccine Revenue and Market Share by Type (2017-2020)
1.3.4 Global Shingles Vaccine Price by Type (2017-2020)

2 Global Shingles Vaccine Market Competition by Company

2.1 Global Shingles Vaccine Sales and Market Share by Company (2017-2020)
2.2 Global Shingles Vaccine Revenue and Share by Company (2017-2020)
2.3 Global Shingles Vaccine Price by Company (2017-2020)
2.4 Global Top Players Shingles Vaccine Manufacturing Base Distribution, Sales Area, Product Types
2.5 Shingles Vaccine Market Competitive Situation and Trends
2.5.1 Shingles Vaccine Market Concentration Rate
2.5.2 Global Shingles Vaccine Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion

3 Shingles Vaccine Company Profiles and Sales Data

3.1 Merck
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Shingles Vaccine Product Category, Application and Specification
3.1.3 Merck Shingles Vaccine Sales, Revenue, Price and Gross Margin(2017-2020)
3.1.4 Main Business Overview
3.2 GlaxoSmithKline
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Shingles Vaccine Product Category, Application and Specification
3.2.3 GlaxoSmithKline Shingles Vaccine Sales, Revenue, Price and Gross Margin(2017-2020)
3.2.4 Main Business Overview

4 Shingles Vaccine Market Status and Outlook by Regions

4.1 Global Market Status and Outlook by Regions
4.1.1 Global Shingles Vaccine Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Shingles Vaccine Sales and Revenue by Regions
4.2.1 Global Shingles Vaccine Sales and Market Share by Regions (2017-2020)
4.2.2 Global Shingles Vaccine Revenue and Market Share by Regions (2017-2020)
4.2.3 Global Shingles Vaccine Sales, Revenue, Price and Gross Margin (2017-2020)
4.3 North America Shingles Vaccine Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Shingles Vaccine Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Shingles Vaccine Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Shingles Vaccine Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Shingles Vaccine Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries

5 Shingles Vaccine Application/End Users

5.1 Shingles Vaccine Segment by Application
5.1.1 Under 50 Years Old
5.1.2 50-60 Years Old
5.1.3 60-70 Years Old
5.1.4 Above 70 Years Old
5.2 Global Shingles Vaccine Product Segment by Application
5.2.1 Global Shingles Vaccine Sales by Application
5.2.2 Global Shingles Vaccine Sales and Market Share by Application (2017-2020)

6 Global Shingles Vaccine Market Forecast

6.1 Global Shingles Vaccine Sales, Revenue Forecast (2021-2028)
6.1.1 Global Shingles Vaccine Sales and Growth Rate Forecast (2021-2028)
6.1.1 Global Shingles Vaccine Revenue and Growth Rate Forecast (2021-2028)
6.2 Global Shingles Vaccine Forecast by Regions
6.2.1 North America Shingles Vaccine Sales and Revenue Forecast (2021-2028)
6.2.2 Europe Shingles Vaccine Sales and Revenue Forecast (2021-2028)
6.2.3 Asia-Pacific Shingles Vaccine Sales and Revenue Forecast (2021-2028)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Shingles Vaccine Sales and Revenue Forecast (2021-2028)
6.2.5 Middle East and Africa Shingles Vaccine Sales and Revenue Forecast (2021-2028)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Shingles Vaccine Forecast by Type
6.3.1 Global Shingles Vaccine Sales and Revenue Forecast by Type (2021-2028)
6.3.2 Zostavax Gowth Forecast
6.3.3 Shingrix Gowth Forecast
6.4 Shingles Vaccine Forecast by Application
6.4.1 Global Shingles Vaccine Sales Forecast by Application (2021-2028)
6.4.2 Global Shingles Vaccine Forecast in Under 50 Years Old
6.4.3 Global Shingles Vaccine Forecast in 50-60 Years Old

7 Shingles Vaccine Upstream Raw Materials

7.1 Shingles Vaccine Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Shingles Vaccine Industrial Chain Analysis

8 Marketing Strategy Analysis, Distributors

8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers

9 Research Findings and Conclusion

Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer